Publication Name	World Journal of Gastroenterology
Manuscript ID	64414
Country	Australia

Received	2021-02-17 02:54
Peer-Review Started	2021-02-17 02:58
To Make the First Decision
Return for Revision	2021-04-05 16:54
Revised	2021-04-19 01:38
Second Decision	2021-09-13 02:28
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2021-09-16 23:54
Articles in Press	2021-09-16 23:54
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2021-10-25 03:19
Publish the Manuscript Online	2021-10-27 07:14

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Role of human nucleoside transporters in pancreatic cancer and chemoresistance
Manuscript Source	Unsolicited Manuscript
All Author List	Carly Jade Carter, Ahmed H Mekkawy and David L Morris
ORCID	Author(s) ORCID Number Carly Jade Carter http://orcid.org/0000-0003-3219-4076 Ahmed H Mekkawy http://orcid.org/0000-0001-7162-8936 David L Morris http://orcid.org/0000-0001-9377-8521
Funding Agency and Grant Number
Corresponding Author	David L Morris, FRCS, FRCS (Ed), MBChB, MD, PhD, Professor, Hepatobiliary and Surgical Oncology Unit, Department of Surgery, St George Hospital, University of New South Wales, Kogarah, Sydney 2217, New South Wales, Australia. david.morris@unsw.edu.au
Key Words	Pancreatic cancer; Gemcitabine; Human nucleoside transporters; Human equilibrative nucleoside transporters; Human concentrative nucleotide transporters; Mucins
Core Tip	Pancreatic cancer continues to be one of the leading causes of cancer-related mortality worldwide, with prevalence expected to increase drastically within the next decade primarily due to difficulties in diagnosis and acquired resistance to chemotherapeutic drugs. Due to this, in-depth work is extremely important for the future diagnosis and treatment of the disease. Human Nucleoside Transporters have been identified as a key target in not only diagnosis but also overcoming chemoresistance. Here, we summarize the information currently available on Pancreatic Cancer and the role of Nucleoside Transporters in chemoresistance.
Publish Date	2021-10-27 07:14
Citation	Carter CJ, Mekkawy AH, Morris DL. Role of human nucleoside transporters in pancreatic cancer and chemoresistance. World J Gastroenterol 2021; 27(40): 6844-6860
URL	https://www.wjgnet.com/1007-9327/full/v27/i40/6844.htm
DOI	https://dx.doi.org/10.3748/wjg.v27.i40.6844

Full Article (PDF)	WJG-27-6844.pdf
Full Article (Word)	WJG-27-6844.docx
Manuscript File	64414_Auto_Edited.docx
Answering Reviewers	64414-Answering reviewers.pdf
Audio Core Tip	64414-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	64414-Conflict-of-interest statement.pdf
Copyright License Agreement	64414-Copyright license agreement.pdf
Peer-review Report	64414-Peer-review(s).pdf
Scientific Misconduct Check	64414-CrossCheck.png
Scientific Misconduct Check	64414-Bing-Gong ZM-2.png
Scientific Editor Work List	64414-Scientific editor work list.pdf
CrossCheck Report	64414-CrossCheck report.pdf